No Prescription

No Prescription
HomeAlpha IndexCategories

Allergy

Anti Bacterial

Anti Convulsants

Anti Depressants

Anti Fungal

Anti Narcoleptic

Anti Viral

Antibiotics

Arthritis

Asthma

Birth Control

Blood Pressure

Cancer

Cardiovascular

Cholesterol

Diabetes

Diuretics

Eye Drops

Gastrointestinal

Hair Care

Herbal & Diet Supplements

Men's Health

Migraines

Muscle Relaxers

Nausea & Vomiting

Other

Pain Medicine

Pet Herbal Remedies

Prescription Drugs 1

Prescription Drugs 2

Prescription Drugs 3

Prescription Drugs 4

Prescription Drugs 5

Prescription Drugs 6

Prescription Drugs 7

Prescription Drugs 8

Prescription Drugs 9

Prescription Drugs 10

Prescription Drugs 11

Prescription Drugs 12

Prescription Drugs 13

Prescription Drugs 14

Prescription Drugs 15

Prescription Drugs 16

Prescription Drugs 17

Respiratory

Skin Care

Stop Smoking

Thyroid

Weight Loss

Women's Health

No Prescription

Alphabetical Index

Categories

Hyzaar Forte Generic Losartan and Hydrochlorthiazide

No Prescription » Prescription Drugs 9 » Hyzaar Forte Generic Losartan and Hydrochlorthiazide

Product Origin: EU (Turkey)This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English.Medical Information:Hyzaar is used to treat high blood pressure. HYZAAR is indicated for the treatment of hypertension. This fixed dose combination is not indicated for initial therapy of hypertension except when the hypertension is severe enough that the value of achieving prompt blood pressure control exceeds the risk of initiating combination therapy in these patientsHyzaar is a combination medication used in the treatment of high blood pressure. One component losartan belongs to a new class of blood pressure medications that work by preventing the hormone angiotensin II from constricting the blood vessels thus allowing blood to flow more freely and keeping the blood pressure down. The other component hydrochlorothiazide is a diuretic that increases the output of urine removing excess fluid from the body and thus lowering blood pressure.Treating high blood pressure. It may be used to decrease the risk of stroke in certain patients with high blood pressure. It may also be used for other conditions as determined by your doctor.Losartan/Hydrochlorothiazide is a combination angiotensin II receptor blocker and diuretic. The angiotensin II receptor blocker works by relaxing the blood vessels. Exactly how the diuretic works to decrease blood pressure is unknown but it helps the kidneys to eliminate fluid and sodium from the body.

Buy Hyzaar Forte Generic Losartan and Hydrochlorthiazide and other Prescription Drugs 9 products online at Medstore.

Buy Online at Medstore - Click Here!

About Hyzaar Forte Generic Losartan and Hydrochlorthiazide:

Product Type: Prescription Drugs 9

Hyzaar Forte( Generic Losartan and Hydrochlorthiazide )

Hyzaar Forte (Generic Losartan and Hydrochlorthiazide)

Generic Losartan and Hydrochlorthiazide

100/25mg 28 Tablets 84(3 x 28 Tablets) Generic Losartan and Hydrochlorthiazide Hyzaar Forte

View more Prescription Drugs 9

Previous Product  Next Product

No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.